GILD

Gilead Sciences, Inc. News Headlines

$93.79
*  
2.50
2.74%
Get GILD Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Portfolio Changes For The Third Quarter 2014
10/9/2014 9:14:00 AM - Seeking Alpha


Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog
10/8/2014 5:10:00 PM - Zacks.com


After Hours Most Active for Oct 8, 2014 : AA, REXX, QQQ, CS, GPS, CX, ABB, KMI, ZNGA, GILD, SIRI, MSFT
10/8/2014 3:44:53 PM - NASDAQ.com News


Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha


Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 10:05:02 AM - Motley Fool


ETF Outlook: Health Care Select Sector SPDR ETF (XLV)
10/8/2014 8:26:45 AM - Marc Chaikin


Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog
10/8/2014 7:14:00 AM - Zacks.com


Gilead Sciences: Hitch Your Wagon To This Biotech Juggernaut Before It Really Takes Off
10/7/2014 7:09:00 PM - Seeking Alpha


Comparing America's 2 Largest Biotechnology Companies
10/7/2014 1:57:00 PM - Seeking Alpha


It Is Getting Ugly Out There
10/7/2014 12:16:00 PM - Seeking Alpha


The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock
10/7/2014 10:05:02 AM - Motley Fool


A Professor Plans His Own EnDOWment Fund For Retirement
10/7/2014 9:58:00 AM - Seeking Alpha


HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha


After Hours Most Active for Oct 6, 2014 : ITUB, BAC, CX, PUK, HSBC, FTR, JDSU, HBAN, BID, GILD, SYMC, FITB
10/6/2014 3:39:52 PM - NASDAQ.com News


If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.
10/6/2014 11:57:00 AM - Seeking Alpha


Gilead: Catalysts In Place For A Big October
10/6/2014 9:44:00 AM - Seeking Alpha


Gilead Sciences: Consolidation Before The Next Step Up
10/6/2014 9:41:00 AM - Seeking Alpha


Johnson & Johnson Takes Aim at Gilead Sciences, inc.
10/6/2014 8:03:03 AM - Motley Fool


Gilead Sciences' Other Important New Drug
10/5/2014 9:33:03 AM - Motley Fool


The Biggest Threat Facing Johnson & Johnson
10/4/2014 1:44:02 PM - Motley Fool


Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone
10/4/2014 11:45:02 AM - Motley Fool


Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
10/4/2014 11:14:03 AM - Motley Fool


Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha


MannKind Receives $150 Million Upfront Payment from Sanofi - Analyst Blog
10/3/2014 4:10:00 PM - Zacks.com


Regeneron-Sanofi's Dupilumab Meets All Endpoints - Analyst Blog
10/3/2014 2:00:00 PM - Zacks.com